Compounds > imatinib mesylate
Page last updated: 2024-09-03

imatinib mesylate and HPV Infection

imatinib mesylate has been researched along with HPV Infection in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aderhold, C; Faber, A; Hoermann, K; Hofheinz, RD; Sauter, A; Schultz, JD; Stern-Straeter, J; Umbreit, C1
Erben, P; Faber, A; Hofheinz, RD; Hörmann, K; Mühlheim, K; Sauter, A; Schultz, JD; Sommer, JU; Thorn, C1
Erben, P; Faber, A; Hoedt, S; Hofheinz, RD; Hörmann, K; Sauter, A; Schultz, JD; Sommer, JU; Thorn, C1
Erben, P; Faber, A; Hoedt, S; Hoermann, K; Hofheinz, RD; Sauter, A; Schultz, DJ; Sommer, U; Stern-Straeter, J1

Other Studies

4 other study(ies) available for imatinib mesylate and HPV Infection

ArticleYear
Imatinib-associated matrix metalloproteinase suppression in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitro.
    Oncology reports, 2014, Volume: 32, Issue:2

    Topics: Antineoplastic Agents; Benzamides; Carcinoma, Squamous Cell; Cell Line, Tumor; Dose-Response Relationship, Drug; Fluorouracil; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Imatinib Mesylate; Matrix Metalloproteinase 14; Matrix Metalloproteinase 2; Matrix Metalloproteinases; Papillomavirus Infections; Piperazines; Pyrimidines

2014
Chemotherapeutic alteration of VEGF-/PDGF- and PDGF-Rα/β expression by imatinib in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro.
    Oncology reports, 2011, Volume: 26, Issue:5

    Topics: Adult; Angiogenic Proteins; Antineoplastic Agents; Benzamides; Carboplatin; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Transformation, Viral; Female; Head and Neck Neoplasms; Human papillomavirus 16; Humans; Imatinib Mesylate; Immunohistochemistry; Male; Middle Aged; Papillomavirus Infections; Piperazines; Platelet-Derived Growth Factor; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Vascular Endothelial Growth Factor A

2011
Chemotherapeutic alteration of β-catenin and c-kit expression by imatinib in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitro.
    Oncology reports, 2012, Volume: 27, Issue:1

    Topics: Antineoplastic Agents; Benzamides; beta Catenin; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Enzyme-Linked Immunosorbent Assay; Head and Neck Neoplasms; Humans; Imatinib Mesylate; Immunohistochemistry; In Vitro Techniques; Papillomavirus Infections; Piperazines; Pyrimidines; Signal Transduction; Stem Cell Factor; Viral Core Proteins

2012
Alteration of MMP-2 and -14 expression by imatinib in HPV-positive and -negative squamous cell carcinoma.
    Oncology reports, 2012, Volume: 28, Issue:1

    Topics: Antineoplastic Agents; Benzamides; Carboplatin; Carcinoma, Squamous Cell; Cell Line, Tumor; Gene Expression; Head and Neck Neoplasms; Human papillomavirus 16; Humans; Imatinib Mesylate; Matrix Metalloproteinase 14; Matrix Metalloproteinase 2; Papillomavirus Infections; Piperazines; Pyrimidines

2012